Page 106 - AN-1-2

Advanced Neurology Aging blood-brain barrier in stroke

metalloproteinases and blood-brain barrier disruption in 15: 523–531.
acute ischemic stroke. Front Neurol, 4: 1–15.
59. Chaturvedi M, Kaczmarek L, 2014, MMP-9 inhibition:
46. Montaner J, Alvarez-Sabín J, Molina CA, et al., 2001, A therapeutic strategy in ischemic stroke. Mol Neurobiol,
Matrix metalloproteinase expression is related to 49: 563–573.
hemorrhagic transformation after cardioembolic stroke. 60. Leonardo CC, Eakin AK, Ajmo JM, et al., 2008, Delayed
Stroke, 32: 2762–2767.
administration of a matrix metalloproteinase inhibitor
47. Liu J, Jin X, Liu KJ, et al., 2012, Matrix metalloproteinase- limits progressive brain injury after hypoxia-ischemia in the
2-mediated occludin degradation and caveolin-1-mediated neonatal rat. J Neuroinflammation, 5: 1–11.
claudin-5 redistribution contribute to blood-brain barrier 61. Leonardo CC, Pennypacker KR, 2009, Neuroinflammation
damage in early ischemic stroke stage. J Neurosci, 32: 3044–3057.
and MMPs: Potential therapeutic targets in neonatal
48. Kamada H, Yu F, Nito C, et al., 2007, Influence hypoxic-ischemic injury. J Neuroinflammation, 6: 1–7.
of hyperglycemia on oxidative stress and matrix 62. Leu S, Day YJ, Sun CK, et al., 2016, tPA-MMP-9 axis plays
metalloproteinase-9 activation after focal cerebral ischemia/ a pivotal role in mobilization of endothelial progenitor cells
reperfusion in rats: Relation to blood-brain barrier from bone marrow to circulation and Ischemic Region for
dysfunction. Stroke, 38: 1044–1049.
angiogenesis. Stem Cells Int, 2016: 5417565.
49. Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, et al., 63. Cai H, Ma Y, Jiang L, et al., 2017, Hypoxia response element-
2019, The importance of selected markers of inflammation regulated MMP-9 promotes neurological recovery via glial
and blood-brain barrier damage for short-term ischemic scar degradation and angiogenesis in delayed stroke. Mol
stroke prognosis. J Physiol Pharmacol, 70: 209–217.
Ther, 25: 1448–1459.
50. Yang C, Hawkins KE, Doré S, et al., 2019, Neuroinflammatory 64. DeMars KM, Yang C, Candelario-Jalil E, 2019,
mechanisms of blood-brain barrier damage in ischemic Neuroprotective effects of targeting BET proteins for
stroke. Am J Physiol Cell Physiol, 316: C135–C153.
degradation with dBET1 in aged mice subjected to ischemic
51. Pawluk H, Woźniak A, Grześk G, et al., 2020, The role of stroke. Neurochem Int, 127: 94–102.
selected pro-inflammatory cytokines in pathogenesis of 65. Weisenburger-Lile D, Dong Y, Yger M, et al., Harmful
ischemic stroke. Clin Interv Aging, 15: 469–484.
neutrophil subsets in patients with ischemic stroke. Neurol
52. Voirin AC, Perek N, Roche F, 2020, Inflammatory stress Neuroimmunol Neuroinflammation, 6: e571.
induced by a combination of cytokines (IL-6, IL-17, TNF-α) 66. Murata Y, Rosell A, Scannevin RH, et al., 2008, Extension
leads to a loss of integrity on bEnd.3 endothelial cells in vitro of the Thrombolytic time window with minocycline in
BBB model. Brain Res, 1730: 146647.
experimental stroke. Stroke, 39: 3372–3377.
53. Dutta S, Sengupta P, 2016, Men and mice: Relating their 67. Boese AC, Eckert A, Hamblin MH, et al., 2020, Human
ages. Life Sci, 152: 244–248.
neural stem cells improve early stage stroke outcome in
54. Zhu W, Guo Z, Yu S, 2016, Higher neutrophil counts before delayed tissue plasminogen activator-treated aged stroke
thrombolysis for cerebral ischemia predict worse outcomes. brains. Exp Neurol, 329: 113275.
Neurology, 86: 1077.
68. Zhu S, Szeto V, Bao M, et al., 2018, Pharmacological
55. Inzitari D, Giusti B, Nencini P, et al., 2013, MMP9 approaches promoting stem cell-based therapy following
variation after thrombolysis is associated with hemorrhagic ischemic stroke insults. Acta Pharmacol Sin, 39: 695–712.
transformation of lesion and death. Stroke, 44: 2901–2903.
69. Wu J, Sun Z, Sun HS, et al., Intravenously administered bone
56. Fan X, Qiu J, Yu Z, et al., 2012, A rat model of studying marrow cells migrate to damaged brain tissue and improve
tissue-type plasminogen activator thrombolysis in ischemic neural function in ischemic rats. Cell Transplant, 16: 993–1005.
stroke with diabetes. Stroke, 43: 567–570.
70. Wang R, Zhu Y, Liu Z, et al., 2021, Neutrophil extracellular
57. Umlauf BJ, Shusta EV, 2019, Exploiting BBB disruption for traps promote tPA-induced brain hemorrhage via cGAS in
the delivery of nanocarriers to the diseased CNS. Curr Opin mice with stroke. Blood, 138: 91–103.
Biotechnol, 60: 146–152.
71. Knecht T, Story J, Liu J, et al., 2017, Adjunctive therapy
58. Dziedzic T, 2015, Systemic inflammation as a therapeutic approaches for ischemic stroke: Innovations to expand time
target in acute ischemic stroke. Expert Rev Neurother, window of treatment. Int J Mol Sci, 18: 2756.

Volume 1 Issue 2 (2022) 10 https://doi.org/10.36922/an.v1i2.1